skip to Main Content

TGen Study identifies Potential New Drug Targets to Alleviate Pain in Pancreatic Cancer Patients

Newsfeed image, light gray text on dark gray background
The Translational Genomics Research Institute (TGen) has discovered potential drug targets to reduce pain in pancreatic cancer patients.

TGen researchers have found that nerve growth factor (NGF), a neurotrophic factor, and its receptor TRKA are associated with perineural invasion (PNI), which is the ability of pancreatic cancer cells to invade surrounding nerves. Read more . . .

Back To Top